Nitric oxide modulates placental prostanoid production from late pregnant non-insulin-dependent diabetic rat

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 59, Issue 5, 1998, Pages 299-304

  Gonzalez E ^a   Jawerbaum, A ^a   Novaro, V ^a   Sinner, D ^a   Gimeno, M ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTANOID; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DELIVERY; ENZYME ACTIVITY; FEMALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

ANIMALIA;

EID: 0032446829     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(98)90077-1     Document Type: Article

References (30)

1. Chieri R. A., Pivetta O. H., Foglia V. G. Altered ovulation pattern in experimental diabetes. Fertil Steril 1969; 20: 661-666.
2. Damm P., Molsted-Pedersen L. Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol 1989; 161: 1163-1167.
3. Portha B., Picon L., Rosellin G. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 1979; 17: 371-377.
4. Kergoat M., Guerre-Milo M., Lavau M., Portha B. Increased insulin action in rats with mild insulin deficiency induced by neonatal streptozotocin. Am J Physiol 1991; 260: E561-E567.
5. Tridau N., Portha B., Picon L., Rosselin G. Experimental Chemical Diabetes and Pregnancy in the rat. Dtabets 1982; 31: 75-79.
6. Jawerbaum A., Roselló-Catafau J., González E., Novaro V., Gómez G., Gelpi E., Gimeno A. L., Gimeno M. A. F. Eicosanoid production by uterine strips and by embryos obtained from diabetic pregnant rats. Prostaglandins 1993; 45: 487-495.
7. Jawerbaum A., Roselló-Catafau J., González E., Novaro V., Gómez G., Gelpi E., Vitullo A., Gimeno M. A. F. Prostaglandins, Leukotrienes and Ess Fatty Acids 1997; 56: 425-429.
8. Jawerbaum A., Roselló-Catafau J., González E. T. Novaro V., Gómez G., Gelpí E., Gimeno M. A. F. Eicosanoid production, metabolism and contractile activitiy in the isolated uterus from non-insulin-dependent diabetic rats during late pregnancy. Prostaglandins 1996; 51: 307-320.
9. Conrad K P., Joffe G. M., Kruszyna H. et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993a; 7: 566-571.
10. Conrad K. P., Vill M., McGuire P., Dall W. G., Davis A. K. Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J 1993b; 7: 1269-1276.
11. Myatt L., Brockman D. E., Langdon J., Pollock J. S. Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 1993; 14: 373-383.
12. Schonfelder G., John M., Hopp H., Fuhr N., van-Der-Giet M., Paul M. FASEB J 1996; 10: 777-784.
13. 1 and 5-HETE in vitro: stimulatory action of nitric oxide. Prost Leuk and Essential Fatty Acids 1995; 56: 347-350.
14. 2 release from the hypothalamus. Proc Natl Acad Sci 1995; 89: 11543-11544.
15. 2α concentration in the cervical mucus and mechanism of cervical ripening. Prostaglandins 1997; 53: 253-261.
16. Kelly R. Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocrine Rew 1994; 15: 684-706.
17. Adamson S., Edwin S. S., LaMarche S., Mitchell M. D. Actions of Interleukin-4 on prostaglandin biosynthesis by human amnion cells. Prost Leuk and Essential Fatty Acids 1994; 50: 133-135.
18. Albert T. J., Su H. C., Zimmerrman P. D., Iams J. D., Kniss D. A. Interleukin-1β regulates the inducible cyclooxygenase in amnion-derived WISH cells. Prostaglandins 1994; 48: 401-416.
19. Sternesjo J., Welsh N., Sandier S. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo. Cytokine 1997; 9: 352-359.
20. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
21. Mallof B. L., Boyd B. K. Physiologic and cellular insulin action in a glucose-intolerant model of type 2 (non-insulin-dependent) diabetes in rats. Diabetologia 1986; 29: 295-300.
22. Jawerbaum A., Roselló-Catafau J., González E. T. et al. Glucose metabolism, triglyceride and glycogen levels, as well as eicosanoid production in isolated uterine strips and in embryos in a rat model of non-insulin-dependent diabetes mellitus during pregnancy. Prostaglandins 1994; 47: 81-95.
23. Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989; 86: 9030-9033.
24. 2+ independent nitric oxide synthases. FEBS J 1991; 291: 145-149.
25. Khun D. C., Botti J. J., Cherouny P. H., Demers L. M. Eicosanoid production and transfer in the placenta of the diabetic pregnancy. Prostaglandins 1990; 49: 205-215.
26. Williamson J. R., Chang K., Frangos M. et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993; 42: 801-813.
27. 2 with gestational age in the rat. Biol Reprod 1982; 27: 1207-1215.
28. Mitchell M. D. Sources of eicosanoids within the uterus during pregnancy. In: McNellis D., Challis J. R. G., Mac Donald P. C., Nathanielsz P. W., Roberts J. (Eds). The onset of labor: Cellular and integrative mechanisms. Ithaca, NY: Perinatology Press 1988: 165-181.
29. Thanda M., Saheki S., Kitagawa H., Yano J., Matsuura S. Gestational changes in nitric oxide synthase activity in the rat placenta. J Obstet Gynaecol Res 1996; 22: 267-273.
30. Purcell T. L., Buhimschi I. A., Given R, Chwalisz K., Garfield R. E. Inducible nitric oxide synthase is present in the rat placenta at the fetal-maternal interface and decreases prior to labour. Mol Hum Reprod 1997; 3: 485-491.